AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Jennifer Beauprez
Nov. 18--Larry Blankenship and his three colleagues at CardioOptics Inc. pulled all-nighters trying to build a device that, for the first time, could let heart surgeons see through blood during operations.
They even went without paychecks for a year while stumping for venture capital money and traveling the country to win the backing of the nation's best surgeons.
They got both. Now comes the hard part: using $4.5 million in financing, CardioOptics must turn the dream into reality.
If the firm is successful with upcoming animal and clinical trials, surgeons could be using the device by mid-2003 to treat a range of heart conditions, said Blankenship, the company's chief executive.
"I feel like someone who has been…